Klivira
Request demo

Vabysmo Prior Authorization for Dermatology: Navigating Complexities

While Vabysmo is an ophthalmic therapy, dermatology practices frequently manage complex prior authorizations for specialty drugs and procedures. Klivira streamlines Vabysmo prior authorization for dermatology referrals and other high-volume PAs.

Revenue cycle directors and prior authorization coordinators in dermatology face increasing administrative burdens. Managing prior authorizations for high-cost biologics, specialty topicals, and complex procedures like Mohs surgery demands precise documentation and adherence to evolving payer policies. Klivira provides the automation and intelligence needed to navigate these challenges effectively.

Understanding Vabysmo in the Dermatology Context

Vabysmo (faricimab) is indicated for ophthalmic conditions such as neovascular (wet) age-related macular degeneration and diabetic macular edema. While not a dermatological treatment, multi-specialty groups or practices managing patient referrals may encounter Vabysmo prior authorization for dermatology patients with co-occurring ophthalmic conditions. This highlights the need for a flexible PA platform capable of handling diverse specialty requirements across the healthcare ecosystem.

The Prior Authorization Landscape in Dermatology

Dermatology practices contend with a high volume of prior authorizations, predominantly for biologics used in conditions like psoriasis, psoriatic arthritis, and atopic dermatitis. Procedures such as Mohs micrographic surgery and certain advanced skin cancer treatments also frequently trigger PA requirements. Navigating these diverse categories demands a deep understanding of payer-specific guidelines and clinical criteria.

Essential Documentation for Dermatology Prior Authorizations

  • Diagnosis confirmation with severity scores (e.g., PASI, BSA for psoriasis; EASI, SCORAD for atopic dermatitis).
  • Documentation of prior topical, phototherapy, or conventional systemic therapy trials, demonstrating step therapy compliance.
  • Results from pre-biologic screenings, including TB and hepatitis panels.
  • For Mohs surgery, adherence to AAD Appropriate Use Criteria, specifying tumor type and anatomically sensitive site.
  • Age-appropriate criteria for specific biologics, as per FDA indications.

Common Prior Authorization Denial Reasons in Dermatology

Denials for dermatological treatments often stem from insufficient documentation of step therapy adherence, particularly for biologics. Other frequent issues include failure to document disease severity scores, non-conformance with Mohs Appropriate Use Criteria, or missing pre-biologic screening results. These challenges underscore the need for rigorous workflow automation and intelligent validation.

Klivira's Approach to Dermatology Prior Authorization Automation

Klivira's platform is engineered to streamline the complex prior authorization workflows inherent to dermatology. We leverage AAD-guideline-aware logic for biologics, validate Mohs surgery against AUC, and manage periodic re-authorization cycles for chronic treatments. Our system also intelligently routes requests based on medical versus pharmacy benefit, reducing manual intervention and accelerating approvals.

Optimizing Dermatology PA Workflows with Klivira

  • Automated tracking and submission for periodic re-authorization of chronic biologic therapies.
  • Intelligent routing of medical-vs-pharmacy benefit claims for self-injectable and infused biologics.
  • Validation against AAD-guidelines for step-therapy requirements for psoriasis and atopic dermatitis biologics.
  • Support for high-volume Mohs surgery prior authorizations, including AUC conformance checks.
  • Distinction and appropriate handling for cosmetic vs. medical procedure prior authorizations.

Frequently asked questions

How does Klivira address the high volume of biologic prior authorizations in dermatology?

Klivira automates the submission and tracking of prior authorizations for high-volume biologics used in dermatology, such as those for psoriasis and atopic dermatitis. Our platform integrates with EMRs to pull necessary clinical data, applies payer-specific rules, and manages step therapy requirements to accelerate approvals.

What specific challenges does Klivira solve for Mohs surgery prior authorizations?

For Mohs surgery, Klivira validates against AAD Appropriate Use Criteria to ensure all required documentation, such as tumor type and site, is present and compliant with payer policies. This proactive validation significantly reduces denials related to AUC mismatches and streamlines the approval process.

Can Klivira manage re-authorizations for chronic dermatology conditions?

Yes, Klivira's system is designed to manage the periodic re-authorization cycles common for chronic biologic treatments in dermatology. It provides automated reminders and pre-populates re-authorization requests with updated patient data, ensuring timely submissions and continuous patient access to therapy.

How does Klivira handle the distinction between medical and pharmacy benefits for dermatology drugs?

Klivira intelligently routes prior authorization requests based on whether the drug falls under the medical or pharmacy benefit. This is crucial for dermatology biologics, which can be self-injected (pharmacy) or clinic-infused (medical), ensuring the correct channel is used for submission and avoiding unnecessary delays.

What role do clinical guidelines play in Klivira's dermatology PA process?

Klivira incorporates logic based on established clinical guidelines, such as those from the AAD, to guide the prior authorization process. This includes validating step therapy requirements for psoriasis and atopic dermatitis biologics and ensuring documentation aligns with payer interpretations of these guidelines, improving approval rates.

Related coverage

Other vabysmo prior authorization by payer

Other vabysmo prior authorization by specialty

Ready to automate prior auth for this drug?

See how Klivira automates prior authorizations for your team.

Request a demo